You’ve spent years building the science. The data is solid. The submission is in.

And then you walk into an FDA Advisory Committee meeting (AdCom), where everything depends on how well your team explains, defends, and stands behind that work in real time.

An FDA Advisory Committee meeting (AdCom) is a high-stakes public forum where external experts evaluate your drug’s safety, efficacy, and overall benefit-risk profile—and vote on whether it should move forward.

AdComs are live, high-pressure evaluations for pharmaceutical companies. Panelists challenge assumptions, probe for gaps, and test how clearly and confidently your team can respond. And while the FDA doesn’t have to follow the AdCom panel’s recommendation, it often does.

Which means this moment can shape not just approval, but how your product is perceived by regulators, investors, and the public.

Let’s break down how to prepare for an FDA AdCom, where teams typically struggle, and what separates confident performances from costly missteps.

Where do pharma teams struggle with AdCom preparation?

The most common mistake I see companies make is treating AdCom preparation as a sprint. They lock in their scientific briefing documents, then scramble to prepare speakers in the final weeks before the meeting.

Success in the room isn’t just about knowing the data. It’s about making it understood—quickly, clearly, and under pressure.

Your communications preparation should begin at least six months out. Not because the messaging takes that long to develop, but because your presenters and subject-matter experts need time to internalize it, rehearse it, and make it their own.

I have coached presenters and the ‘bench’ of responders from virtually all the big pharma companies and many biotechnology companies. The challenge is always the same: the subject matter experts know too much. When you live and breathe your data, it becomes difficult to imagine what it’s like to hear it for the first time.

Early preparation gives you time to study the landscape. What AdCom meetings have taken place in your therapeutic area? What questions did panelists ask? What tripped up other sponsors? The record is there—use it. Watch past meetings if you can access recordings. Read the transcripts. The committee members are scientists, but not all are specialists in your product’s therapeutic area. The one thing you should assume they all have in common? They’re skeptical and serve their term on the committee to poke holes in your data. It is one big pressure test of stamina!

Why is Q&A the most critical part of an FDA AdCom?

Presentations matter. But it is the Q&A that decides everything.

This is where panelists push hardest—and where even strong teams can start to unravel.

The teams that hold up best build what I call a “bullpen”: a defined group of subject-matter experts who are coached, not just briefed. Each person owns a topic, anticipates the toughest questions, and can respond with clarity and composure in the moment.

That preparation shows up in a few critical ways:

• Anticipate the hardest questions. You pressure-test your own story first. Identify the weakest points in your data and build answers that are stronger than the questions you expect.
• Assign clear topic ownership. You coach individuals, not just the group. Every responder needs to deliver answers clearly and confidently—not just accurately. At Yes& CommCore, we tailor each spokesperson’s training to sharpen their message, manage body language, and stay composed when panelists push back.
• Rehearse under pressure. You rehearse for discomfort. Mock sessions should feel harder than the real thing. Fresh eyes, tough questions, time pressure.
• Return to key messages. You stay on message—no matter what. One off-track answer can undo hours of careful communication. Every member of the presenting team must know the top key messages of your application and be able to return to them naturally, even when questioning pulls in a different direction.

What should you expect during an FDA advisory committee meeting?

AdComs are public, high-visibility events. Panelists, FDA staff, patient advocates, investors, journalists, and competitors are all paying attention. And during the open public hearing, patient voices can shift the tone in ways you can’t predict.

You can’t control the room. But you can prepare for it.

That means coaching presenters on more than content—how they show up, how they handle silence, how they stay composed when the questions get pointed. Because credibility isn’t just built on what you say. It’s how you carry it.

How Yes& Helps Teams Show Up Ready

We treat AdCom prep as performance under pressure, because that’s what it is.

We work with scientific and communications leaders to shape clear, defensible messaging early. Then we coach each presenter individually, helping them translate complex data into answers that land in the room.

And we build alignment behind the scenes—so when the questions come fast, your team stays coordinated, confident, and on message.

Because in that moment, clarity isn’t a nice-to-have. It’s what moves decisions forward.

The Bottom Line

Your communications work has just started when the committee adjourns. Investors, journalists, patient advocates, and employees are watching in real time. Your communications team should have holding statements, internal messages, and post-meeting materials ready to deploy regardless of the outcome.

An AdCom isn’t just a scientific review that happens to be public—it’s a communications moment that can define what happens next. The teams that recognize that early show up ready to be understood.

At Yes&CommCore, we’ve spent decades coaching executives, scientists, and spokespersons for the moments that matter most. Advisory committee meetings are among the highest of those moments. The preparation is demanding. The stakes are real. And in our experience, there is no such thing as being too prepared.

Got an AdCom on the calendar? Let’s pressure-test your messaging, train your presenters, and build a Q&A strategy that holds up in the room.

Frequently Asked Questions